The Durham-based parent company says it still plans to grow Q2 Solutions’ local headcount despite the grant terminations.

Novo Nordisk is preparing to launch Wegovy in India, where millions of people are battling obesity and demand for the weight-loss drug is expected to be massive. The drug will be launched in ...

Oprah Winfrey and Elon Musk endorsed it. And though Indian celebrities haven’t yet admitted to their use, the mystery slimming of Bollywood filmmaker Karan Johar and TV talk show host Kapil Sharma ...

IQVIA data through 5/16 showing Vevye ticking way up to the high for 2025. And that's pretty interesting since starting April 1 IQVIA is missing something like 1/3 of all NRx. Just saying.

Full-year 2025 revenue guidance was raised by $275 million, now ranging between $16 billion and $16.4 billion, representing 3.9% to 6.5% reported growth. Adjusted EBITDA guidance remains at $3.765 ...

Clinical research company IQVIA (NYSE: IQV) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 2.5% year on year to $3.83 billion. The company’s full-year revenue ...

Clinical research company IQVIA (NYSE: IQV) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 2.5% year on year to $3.83 billion. The company’s full-year ...

Today 27, 17–30; 2022) to the most recent published BIO and IQVIA clinical trial success rates for all therapeutic modalities for all therapeutic areas (see Related links).

IQVIA Holdings Inc. (NYSE:IQV) Q4 2024 Earnings Call Transcript February 6, 2025 IQVIA Holdings Inc. beats earnings expectations. Reported EPS is $3.12, expectations were $3.11. Operator: Ladies ...